Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy plus metformin for recurrence reduction in ovarian cancer
IRCT2016022726788N1Phase 2Completed
- Sponsor
- Vice chancellor of research, Shiraz University of Medical Sciences
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of metformin in ovarian cancer and epithelial ovarian cancer (EOC), sponsored by Vice chancellor of research, Shiraz University of Medical Sciences. Started Feb 2011; status: completed.
02
Drugs
metformin
03
Conditions
ovarian cancerepithelial ovarian cancer (EOC)
Beyond the preview
Go deeper on IRCT2016022726788N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016022726788N1.